282 related articles for article (PubMed ID: 15129369)
1. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
[TBL] [Abstract][Full Text] [Related]
2. CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese women.
Gorai I; Inada M; Morinaga H; Uchiyama Y; Yamauchi H; Hirahara F; Chaki O
Bone; 2007 Jan; 40(1):28-36. PubMed ID: 16971197
[TBL] [Abstract][Full Text] [Related]
3. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in CYP17, COMT, and ESR1 genes in women after menopause and association with bone mineral density.
Gonçalves CG; Almeida BC; Camargo-Kosugi CM; Costa AM; Silva ID; Haidar MA
Genet Mol Res; 2015 Dec; 14(4):15802-10. PubMed ID: 26634548
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
[TBL] [Abstract][Full Text] [Related]
6. Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women.
Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):815-20. PubMed ID: 15824149
[TBL] [Abstract][Full Text] [Related]
7. A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men.
Zmuda JM; Cauley JA; Kuller LH; Ferrell RE
J Bone Miner Res; 2001 May; 16(5):911-7. PubMed ID: 11341336
[TBL] [Abstract][Full Text] [Related]
8. Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population.
Corbo RM; Gambina G; Broggio E; Scarabino D; Scacchi R
J Neurol Sci; 2014 Sep; 344(1-2):149-53. PubMed ID: 25012481
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
[TBL] [Abstract][Full Text] [Related]
11. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.
Somner J; McLellan S; Cheung J; Mak YT; Frost ML; Knapp KM; Wierzbicki AS; Wheeler M; Fogelman I; Ralston SH; Hampson GN
J Clin Endocrinol Metab; 2004 Jan; 89(1):344-51. PubMed ID: 14715870
[TBL] [Abstract][Full Text] [Related]
13. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
14. Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk.
González-Bofill N; Husted LB; Harsløf T; Tofteng CL; Abrahamsen B; Eiken P; Vestergaard P; Langdahl BL
Osteoporos Int; 2011 Apr; 22(4):1145-56. PubMed ID: 20571774
[TBL] [Abstract][Full Text] [Related]
15. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
[TBL] [Abstract][Full Text] [Related]
16. Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study.
Tofteng CL; Jensen JE; Abrahamsen B; Odum L; Brot C
J Bone Miner Res; 2002 Aug; 17(8):1535-44. PubMed ID: 12162507
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.
Kim J; Kim H; Ku SY; Suh CS; Kim JH; Kim JG
Climacteric; 2016; 19(1):85-90. PubMed ID: 26624862
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
20. Association of estrogen receptor alpha gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy.
Yim CH; Choi JT; Choi HA; Kang YS; Moon IG; Yoon HK; Han IK; Kang DH; Han KO
J Bone Miner Metab; 2005; 23(5):395-400. PubMed ID: 16133690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
